Compare · CGNX vs TMO
CGNX vs TMO
Side-by-side comparison of Cognex Corporation (CGNX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGNX and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 27.5x CGNX ($9.37B).
- Over the past year, CGNX is up 17.4% and TMO is up 28.0% - TMO leads by 10.6 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 4 for CGNX).
- Both have 25 recent analyst ratings on file.
- Company
- Cognex Corporation
- Thermo Fisher Scientific Inc
- Price
- $54.01-2.99%
- $690.13-0.92%
- Market cap
- $9.37B
- $257.53B
- 1M return
- -11.29%
- +4.77%
- 1Y return
- +17.38%
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 1989
- News (4w)
- 4
- 7
- Recent ratings
- 25
- 25
Cognex Corporation
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; Cognex Designer that allows customers to build vision applications with a graphical, flowchart-based programming environment; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; and vision sensors for vision applications, such as checking the presence and size of parts; the In-Sight product line of vision systems and sensors. In addition, the company offers ID products comprising DataMan image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. The company was founded in 1981 and is headquartered in Natick, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest CGNX
- Cognex Announces Third Quarter 2026 Earnings Release and Conference Call Dates
- Cognex Launches New Wafer Reader to Help Semiconductor Manufacturers Scale Production
- Cognex Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Cognex to Acquire RealSense, Expanding Machine Vision Leadership into High-Growth Robotic Perception Market
- Cognex to Present at the Morgan Stanley 14th Annual Laguna Conference
- CEO & President Moschner Matthew exercised 16,600 shares at a strike of $45.72 and sold $1,597,749 worth of shares (24,962 units at $64.01) as part of a pre-agreed trading plan, decreasing direct ownership by 43% to 10,884 units (SEC Form 4)
- Vice President Long Darren Marc converted options into 2,500 shares and covered exercise/tax liability with 734 shares, increasing direct ownership by 44% to 5,756 units (SEC Form 4) to cover withholding tax
- CEO & President Moschner Matthew converted options into 4,999 shares and covered exercise/tax liability with 2,218 shares, increasing direct ownership by 17% to 19,246 units (SEC Form 4) to satisfy withholding obligation
- Cognex downgraded by HSBC Securities with a new price target
- SEC Form 10-Q filed by Cognex Corporation
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)